Results 141 to 150 of about 81,713 (355)

Road traffic pollution and childhood leukemia: a nationwide case-control study in Italy [PDF]

, 2016
Background The association of childhood leukemia with traffic pollution was considered in a number of studies from 1989 onwards, with results not entirely consistent and little information regarding subtypes.
Alberto Salvan, Alessandra Benvenuti, Alessandra Greco Veneto, Alessandra Ranucci, Alessandra Ranucci, Alessandro Polichetti, Alessandro Pulsoni, Andrea Farioli, Andrea Pession, Carmelo Rizzari, Chiara Badaloni, Claudia Galassi, Corrado Magnani, Corrado Magnani, Cristina Nuccetelli, Daniela Ferrante, Daniela Ferrante, Daniele Monetti, Domenico Franco Merlo, Domenico Franco Merlo, Egidio Celentano, Egidio Celentano, Erni Guarino, Francesco Bochicchio, Francesco Forastiere, Francesco Forastiere, Franco Locatelli, Franco Pannelli, Gabriella Bernini, Gian Luca DeSalvo, Gigliola de Nichilo, Gino Schilirò, Giorgio Assennato, Giorgio Assennato, Giulia Cesaroni, Giuseppe Masera, Giuseppe Sampietro, Lia Lidia Luzzatto, Liliana Minelli, Liliana Minelli, Lorenzo Gafà, Lucia Miligi, Lucia Miligi, Luigi Bisanti, Luigi Bisanti, Manuela Chiavarini, Maria Valeria Torregrossa, Maria Valeria Torregrossa, Marina Cuttini, Marina Cuttini, Maurizio Aricò, Paola Michelozzi, Paola Michelozzi, Paola Mosciatti, Paola Mosciatti, Paola Zambon, Paola Zambon, Pia Massaglia, Pierfranco Biddau, Pierluigi Cocco, Pierluigi Cocco, Riccardo Haupt, Riccardo Haupt, Roberto Rondelli, Roberto Rondelli, Roberto Targhetta, Rosaria Maria Valenti, Santina Cannizzaro, Santina Cannizzaro, Serena Risica, Stefania Varotto, Stefano Mattioli, Stefano Mattioli, Stefano Parodi, Susanna Lagorio, Susanna Lagorio, Ursula Kirchmayer, Veronica Casotto, Vincenzo Poggi, Vittorio Bocchini   +79 more
core   +1 more source

ACUTE LYMPHOBLASTIC LEUKEMIAS AND LYMPHOMAS OF CHILDHOOD WITH T CELL ORIGIN: CLINICAL FEATURES AND PROGNOSIS [PDF]

, 1974
John H. Kersey, Kazimiera J. Gajl‐Peczalska, John R. Luckasen, Hark E Nesbit   +3 more
openalex   +1 more source

A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Developing targeted therapies with manageable toxicities remains a high priority for pediatric cancer. We sought to determine the recommended Phase 2 dose (RP2D) and evaluate the antitumor activity of lenvatinib+everolimus in children/young adults with select recurrent/refractory solid tumors.
Filemon S. Dela Cruz, Elizabeth Fox, Steven G. DuBois, Gregory K. Friedman, James M. Croop, AeRang Kim, Daniel A. Morgenstern, Frank M. Balis, Margaret E. Macy, Joseph G. Pressey, Tanya Watt, Julie I. Krystal, Kieuhoa T. Vo, Rajen Mody, Theodore W. Laetsch, Brenda J. Weigel, Karen O'Hara, Cixin S. He, Jagadeesh Aluri, Chinyere E. Okpara, Julia L. Glade Bender   +20 more
wiley   +1 more source

Understanding the role of B-cells in CAR T-cell therapy in leukemia through a mathematical model [PDF]

arXiv
Chimeric Antigen Receptor T (CAR-T) cell therapy has been proven to be successful against different leukaemias and lymphomas. This paper makes an analytical and numerical study of a mathematical model describing the competition of CAR-T, leukaemias tumor and B cells.
arxiv  

Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma [PDF]

, 1981
A Bernard, L Boumsell, EL Reinherz, LM Nadler, Jerome Ritz, Hélène Coppin, Yolande Richard, F Valensi, J Dausset, Georges Flandrin, J Lemerle, SF Schlossman   +11 more
openalex   +1 more source

Late Mortality Among Survivors of Childhood Cancer in Canada: A Retrospective Cohort Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Children with cancer face an increased risk of complications and death beyond the 5‐year survival mark. National surveillance efforts facilitate the systematic tracking of long‐term health outcomes, including treatment‐related complications and late mortality, among childhood cancer survivors.
Katherine McKenzie, Brianna Belanger, Shruti Parshad, Lin Xie, Vera Grywacheski, Miranda Fidler‐Benaoudia   +5 more
wiley   +1 more source

Terminal deoxynucleotidyl transferase-containing cells in peripheral blood: implications for the surveillance of patients with lymphoblastic leukemia or lymphoma in remission [PDF]

, 1981
TW Froehlich, GR Buchanan, JA Cornet, P Sartain, RG Smith   +4 more
openalex   +1 more source

What Is the Expected Clearance of Methotrexate? A Therapeutic Drug Monitoring Reference Guide for High‐Dose Methotrexate Use in Pediatric Malignancies

Pediatric Blood &Cancer, EarlyView.
ABSTRACT High‐dose methotrexate dosage and infusion durations differ across treatment protocols for pediatric leukemia, lymphoma, and osteosarcoma. Supportive care interventions are dependent on a patient's elimination of methotrexate (MTX). Therefore, it is important to establish the expected MTX elimination across protocols.
Zachary L. Taylor, Tamara P. Miller, Sarah G. Board, Ethan A. Poweleit, Ashley Chavana, Allison Weisnicht, Austin L. Brown, Melanie B. Bernhardt, Eric S. Schafer, Maureen M. O'Brien, Sharon M. Castellino, Laura B. Ramsey   +11 more
wiley   +1 more source

Molecular mechanisms in haematological malignancies [PDF]

, 2009
Haematopoiesis requires the constant production of large numbers of peripheral blood cells. This process is under tight control of transcription factor networks as well as cytokines, growth factors and hormones.
Avellino, Roberto, Grech, Godfrey, Schembri-Wismayer, Pierre   +2 more
core  

Reactive histiocytosis in acute lymphoblastic leukemia and non-hodgkin' s lymphoma [PDF]

, 1986
Der‐Cherng Liang, Marie Lin Chu, Chi-Ching Shih   +2 more
openalex   +1 more source